Suppr超能文献

清道夫受体凝集素胎盘1(CL-P1)主要介导人血管内皮细胞对酵母聚糖的吞噬作用。

Scavenger receptor collectin placenta 1 (CL-P1) predominantly mediates zymosan phagocytosis by human vascular endothelial cells.

作者信息

Jang SeongJae, Ohtani Katsuki, Fukuoh Atsushi, Yoshizaki Takayuki, Fukuda Mitsuko, Motomura Wataru, Mori Kenichiro, Fukuzawa Jun, Kitamoto Noritoshi, Yoshida Itsuro, Suzuki Yasuhiko, Wakamiya Nobutaka

机构信息

Department of Microbiology and Immunochemistry, Asahikawa Medical College, Asahikawa 078-8510, Japan.

出版信息

J Biol Chem. 2009 Feb 6;284(6):3956-65. doi: 10.1074/jbc.M807477200. Epub 2008 Dec 10.

Abstract

Collectin placenta 1 (CL-P1), a recently discovered scavenger receptor, mediates the uptake of oxidized low density lipoprotein and microbes. In this study, we investigated CL-P1-mediated binding and ingestion of yeast-derived zymosan bioparticles using Chinese hamster ovary (CHO) cells stably expressing human CL-P1 (CHO/CL-P1) and human vascular endothelial cells constitutively expressed CL-P1. The uptake of zymosan by CHO/CL-P1 was dependent upon the level of CL-P1 expressed on the membrane and was inhibited by cytochalasin D and wortmannin. The binding of zymosan was also inhibited by ligands of other scavenger receptors such as poly(I) and dextran sulfate. Real time reverse transcription-PCR analyses showed that other scavenger receptors, namely LOX-1, Stabilin-2, or macrophage receptor with collagenous structure (MARCO), were not expressed in human umbilical vein endothelial cells isolated from different individuals. Nonopsonic zymosan ingestion was inhibited in three primary cultured vascular endothelial cells, including different human umbilical vein endothelial cells from nine individuals treated with CL-P1 small interfering RNAs, although small interfering RNAs of other scavenger receptors had no effect on zymosan uptake in these cells. Furthermore, we confirmed that CL-P1 is expressed in human and murine vascular endothelial layers. Our results demonstrated that CL-P1 predominantly mediated phagocytosis for fungi in vascular endothelia.

摘要

收集素胎盘1(CL-P1)是一种最近发现的清道夫受体,介导氧化型低密度脂蛋白和微生物的摄取。在本研究中,我们使用稳定表达人CL-P1的中国仓鼠卵巢(CHO)细胞(CHO/CL-P1)和组成性表达CL-P1的人血管内皮细胞,研究了CL-P1介导的酵母来源的酵母聚糖生物颗粒的结合和摄取。CHO/CL-P1对酵母聚糖的摄取取决于膜上表达的CL-P1水平,并受到细胞松弛素D和渥曼青霉素的抑制。酵母聚糖的结合也受到其他清道夫受体配体的抑制,如聚肌苷酸和硫酸葡聚糖。实时逆转录-PCR分析表明,其他清道夫受体,即凝集素样氧化低密度脂蛋白受体1(LOX-1)、稳定素-2或具有胶原结构的巨噬细胞受体(MARCO),在从不同个体分离的人脐静脉内皮细胞中未表达。在三种原代培养的血管内皮细胞中,非调理酵母聚糖摄取受到抑制,包括来自9个个体的不同人脐静脉内皮细胞用CL-P1小干扰RNA处理,尽管其他清道夫受体的小干扰RNA对这些细胞中的酵母聚糖摄取没有影响。此外,我们证实CL-P1在人和小鼠血管内皮层中表达。我们的结果表明,CL-P1主要介导血管内皮中真菌的吞噬作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验